胃、十二指肠及结直肠癌术后再评估中 18F-FDG 与 68Ga-FAPI-04 摄取的比较
该单中心回顾性临床研究纳入 41 例胃、十二指肠及结直肠癌根治性切除术后患者,比较 68Ga-FAPI-04 PET/CT 与 18F-FDG PET/CT 检测肿瘤复发及淋巴结、远处转移的效能。结果显示 68Ga-FAPI-04 PET/CT 对肿瘤复发、淋巴结转移和远处转移的敏感性均高于 18F-FDG PET/CT。作者认为 68Ga-FAPI-04 PET/CT 在肿瘤再评估中显示出更准确评估胃癌、十二指肠癌和结直肠癌的潜力,从而改善治疗决策。
要点
- 68Ga-FAPI-04 PET/CT 检测肿瘤复发敏感性 6/6(100%)vs 18F-FDG PET/CT 4/6(67%)。
- 68Ga-FAPI-04 PET/CT 检测淋巴结转移敏感性 92/92(100%)vs 18F-FDG PET/CT 31/92(34%)。
- 68Ga-FAPI-04 PET/CT 检测远处转移敏感性 28/30(93%)vs 18F-FDG PET/CT 20/30(67%)。
核心结论
- 68Ga-FAPI-04 PET/CT 用于肿瘤再评估显示出对胃、十二指肠及结直肠癌更准确评估的潜力,从而改善治疗决策。
研究设计与样本
- 单中心回顾性临床研究,在西南医科大学附属医院于 2020 年 1 月至 2022 年 6 月开展,纳入 41 例胃、十二指肠及结直肠癌根治性切除术后患者(中位年龄 51 岁,范围 19-75 岁)。
- 患者均接受 68Ga-FAPI-04 与 18F-FDG PET/CT 检查,以组织病理学检查、形态学影像和/或随访影像作为参考标准。
- 采用配对样本 t 检验比较 18F-FDG 与 68Ga-FAPI-04 PET/CT 间肿瘤复发及淋巴结、远处转移的 SUVmax。
主要发现
- 68Ga-FAPI-04 PET/CT 检测肿瘤复发的敏感性为 6/6(100%),18F-FDG PET/CT 为 4/6(67%)。
- 68Ga-FAPI-04 PET/CT 检测淋巴结转移的敏感性为 92/92(100%),18F-FDG PET/CT 为 31/92(34%)。
- 68Ga-FAPI-04 PET/CT 检测远处转移的敏感性为 28/30(93%),18F-FDG PET/CT 为 20/30(67%)。
关键数值与推荐
- 68Ga-FAPI-04 PET/CT 检测肿瘤复发敏感性 6/6(100%)vs 18F-FDG PET/CT 4/6(67%)。
- 68Ga-FAPI-04 PET/CT 检测淋巴结转移敏感性 92/92(100%)vs 18F-FDG PET/CT 31/92(34%)。
- 68Ga-FAPI-04 PET/CT 检测远处转移敏感性 28/30(93%)vs 18F-FDG PET/CT 20/30(67%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare the potential efficacy of 68 Ga-FAPI-04 PET/CT with that of 18 F-FDG PET/CT for detecting tumor recurrence and nodal and distant metastases in gastric, duodenal, and colorectal cancers. METHODS: This single-center retrospective clinical study was performed at the Affiliated Hospital of Southwest Medical University between January 2020 and June 2022. Participants with gastric, duodenal, and colorectal cancers after curative resection underwent both 68 Ga-FAPI-04 and 18 F-FDG PET/CT. Histopathologic examination, morphologic imaging, and/or follow-up imaging served as the reference standards. The SUV max of the tumor recurrence and nodal and distant metastases between 18 F-FDG and 68 Ga-FAPI-04 PET/CT were compared using the paired-sample t test. RESULTS: Forty-one participants with gastric, duodenal, and colorectal cancers were enrolled in the study (median age, 51 years; range, 19-75 years). The sensitivity of 68 Ga-FAPI-04 PET/CT was higher than that of 18 F-FDG PET/CT for detecting tumor recurrence (6 of 6 [100%] vs 4 of 6 [67%]), nodal metastases (92 of 92 [100%] vs 31 of 92 [34%]), and distant metastases (28 of 30 [93%] vs 20 of 30 [67%]). CONCLUSION: 68 Ga-FAPI-04 PET/CT for tumor re-evaluation showed potential for more accurate performance of gastric, duodenal, and colorectal cancers, thereby improving treatment decision-making.
引用
- Liu H, Yang X, Liu L, et al. Comparison of 18 F-FDG and 68 Ga-FAPI-04 Uptake in Postoperative Re-evaluation of Gastric, Duodenal, and Colorectal Cancers. Clin Nucl Med. 2023. PMID: 36800254. doi:10.1097/RLU.0000000000004604
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。